RT @Osteoporosis_NL: #Aromatase_inhibitors also negatively affected trabecular bone score (#TBS) https://t.co/ragc4u4DtX
RT @Osteoporosis_NL: #Aromatase_inhibitors also negatively affected trabecular bone score (#TBS) https://t.co/ragc4u4DtX
RT @Osteoporosis_NL: #Aromatase_inhibitors also negatively affected trabecular bone score (#TBS) https://t.co/ragc4u4DtX
RT @Osteoporosis_NL: #Aromatase_inhibitors also negatively affected trabecular bone score (#TBS) https://t.co/ragc4u4DtX
RT @Osteoporosis_NL: #Aromatase_inhibitors also negatively affected trabecular bone score (#TBS) https://t.co/ragc4u4DtX
#Aromatase_inhibitors also negatively affected trabecular bone score (#TBS) https://t.co/ragc4u4DtX
RT @iofbonehealth: Long-term effect of #aromataseinhibitors on #bone micro & macro-architecture in non-OP women with #breastcancer https://…
Long-term effect of #aromataseinhibitors on #bone micro & macro-architecture in non-OP women with #breastcancer https://t.co/BoqvHXmXnb
RT @Osteoporosis_NL: #Aromatase_inhibitors also negatively affected trabecular bone score (#TBS) https://t.co/ragc4u4DtX
#Aromatase_inhibitors also negatively affected trabecular bone score (#TBS) https://t.co/ragc4u4DtX
Long-term adjuvant AI #treatment negatively influenced #bonequality in addition to #BMD in pats with #breastcancer. https://t.co/k8TRd70usm https://t.co/wtX8uscBTa